Freedom (Caladrius)

Freedom (Caladrius)

This clinical trial will explore the efficacy and safety of GCSF-mobilized autologous CD34+ cells for the treatment of coronary microvascular dysfunction in adults currently experiencing angina and with no obstructive coronary artery disease.

Please use this link for further information:

Primary Investigator: Timothy Henry